Aandeel 600385 SHANDONG JINTAI GROUP CO., LTD.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Shandong Jintai Group Co., Ltd.

Aandelen

600385

CNE0000018K3

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Shandong Jintai Group Co., Ltd. cancelled the transaction announced on March 4, 2021
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Shandong Jintai Group Co., Ltd. Auditor Raises 'Going Concern' Doubt
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
Shandong Jintai Group Co., Ltd. announced that it expects to receive CNY 155.956825 million in funding from Beijing Towercrest Investment Management Group Co., Ltd
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
Shandong Jintai Group Co., Ltd. Provides Earnings Guidance for the Year 2019
Shandong Jintai Group Co., Ltd. completed the acquisition of Jinan Jinda Pharmaceutical Chemical Co., Ltd. from Beijing Towercrest Investment Management Group Co., Ltd.
Jinan Jintai Pharmaceutical Technology Development Co., Ltd. announced that it expects to receive $12 million in funding from Shandong Jintai Group Co., Ltd.
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019
Shandong Jintai Group Co., Ltd. signed the share acquisition framework agreement to acquire Jinan Jinda Pharmaceutical Chemical Co., Ltd. from Beijing Towercrest Investment Management Group Co., Ltd. for CNY 80 million.
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019
Shandong Jintai Group Co., Ltd. cancelled the acquisition of Fujian Meinkind Baby Products Co., Ltd. from 18 shareholders.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 600385
  4. Nieuws Shandong Jintai Group Co., Ltd.
  5. Andere talen